Stanley Druckenmiller at CNBC's Delivering Alpha on Sept. 28, 2022.Scott Mlyn | CNBCA version of this article first appeared in CNBC's Inside Wealth newsletter...
Hare says she's noticed trackers causing anxiety among her patients."I've noticed more patients coming to me with data from various trackers, with lots of...
The Food and Drug Administration approved a once-daily HIV pill from Gilead that could help simplify care for some patients, the company announced Thursday. The...